{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:16:32Z","timestamp":1791274592366,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,11,13]],"date-time":"2007-11-13T00:00:00Z","timestamp":1194912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2008,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background and Objective.\u2014<\/jats:bold>\n                    Cortical spreading depression and neurogenic inflammation have been hypothesized to be key steps in the development of migraine headache. Recent studies have highlighted matrix metalloproteinase\u20109 (MMP\u20109) in cortical spreading depression, neurogenic inflammation, and cerebral ischemia. To seek their possible association, we investigated plasma MMP\u20109 levels in migraineurs during headache\u2010free periods.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods.\u2014<\/jats:bold>\n                    Plasma MMP\u20109 levels in 84 migraine subjects and 61 controls were determined by enzyme\u2010linked immunosorbent assay. In addition, 23 patients with tension type headache were included in the study as comparative subjects.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    The MMP\u20109 levels in migraineurs (42.5\u2003\u00b1\u20034.6\u2003ng\/mL, mean\u2003\u00b1\u2003SE) were significantly higher than those in controls (25.4\u2003\u00b1\u20032.7\u2003ng\/mL,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u2003.005). Those levels in tension type headache subjects (24.6\u2003\u00b1\u20034.8\u2003ng\/mL) did not differ from those in controls. There was no significant difference between subjects having migraine with aura and those without aura. The MMP\u20109 levels did not correlate with age, duration of illness, frequency of migraine attack, duration of headache attack, or medication for headache. Mean plasma MMP\u20109 levels were the highest in subjects from whom blood samples were taken 2\u20104 days after their latest attack.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.\u2014<\/jats:bold>\n                    The degradation of extracellular matrix showing the increase of MMP\u20109 in migrainurs may be associated with an abnormality in their blood vessel permeability. MPP\u20109 plays some role in migraine pathophysiology. Further studies of MMPs are necessary to elucidate their role.\n                  <\/jats:p>","DOI":"10.1111\/j.1526-4610.2007.00958.x","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T20:29:38Z","timestamp":1195158578000},"page":"135-139","source":"Crossref","is-referenced-by-count":78,"title":["Increased Plasma Matrix Metalloproteinase\u20109 Levels in Migraineurs"],"prefix":"10.1111","volume":"48","author":[{"given":"Keiko","family":"Imamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Fusayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,12,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410330109"},{"key":"e_1_2_7_3_2","first-page":"159","article-title":"Neurovascular and molecular mechanisms in migraine headaches","volume":"5","author":"Moskowitz MA","year":"1993","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh542"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2004.03.070"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02821717"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(97)01169-7"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/35081571"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1373\/49.10.1733"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10108"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421227"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.00246.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2005.05135.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000073788.81170.1C"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.2.191"},{"key":"e_1_2_7_17_2","first-page":"9","article-title":"The International Classification of Headache Disorders: 2nd edn","volume":"24","author":"Headache Classification of the International Headache Society","year":"2004","journal-title":"Cephalalgia"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1397"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1995.64041513.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-200103000-00005"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)03294-7"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.4.427"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2007.00958.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2007.00958.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:13:34Z","timestamp":1762071214000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2007.00958.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1111\/j.1526-4610.2007.00958.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00958.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,20]]}}}